These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15524162)

  • 1. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of beta-adrenergic signaling components for heart failure.
    Koch WJ
    J Card Fail; 2002 Dec; 8(6 Suppl):S526-31. PubMed ID: 12555169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic manipulation of beta-adrenergic signalling in heart failure.
    Davidson MJ; Koch WJ
    Acta Physiol Scand; 2001 Sep; 173(1):145-50. PubMed ID: 11678737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
    Hata JA; Williams ML; Koch WJ
    J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and phenotypic targeting of β-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1):5-9. PubMed ID: 27520660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.
    Port JD; Bristow MR
    J Mol Cell Cardiol; 2001 May; 33(5):887-905. PubMed ID: 11343413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
    J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy and benefits in modulating of system beta-adrenergic in cardiac insufficiency].
    Tevaearai HT; Walton GB; Koch WJ
    Rev Med Suisse Romande; 2002 Mar; 122(3):149-53. PubMed ID: 12014253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of G protein-coupled receptors: GPCR kinases in heart disease.
    Hata JA; Koch WJ
    Mol Interv; 2003 Aug; 3(5):264-72. PubMed ID: 14993440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ; Engelhardt S; Eschenhagen T
    Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure.
    Tevaearai HT; Eckhart AD; Koch WJ
    Minerva Cardioangiol; 2001 Dec; 49(6):389-94. PubMed ID: 11733734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
    Zheng M; Han QD; Xiao RP
    Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex.
    Perrino C; Naga Prasad SV; Schroder JN; Hata JA; Milano C; Rockman HA
    Circulation; 2005 May; 111(20):2579-87. PubMed ID: 15897344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
    Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
    Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
    Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
    J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor.
    Benkusky NA; Weber CS; Scherman JA; Farrell EF; Hacker TA; John MC; Powers PA; Valdivia HH
    Circ Res; 2007 Oct; 101(8):819-29. PubMed ID: 17717301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression of beta-adrenoceptor signal transmitters in heart failure].
    Yu X; Lin S; Wang X
    Zhonghua Yi Xue Za Zhi; 1999 Apr; 79(4):264-7. PubMed ID: 11601053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure].
    Schiattarella GG; Perrino C; Gargiulo G; Sorrentino S; Franzone A; Capretti G; Esposito G; Chiariello M
    G Ital Cardiol (Rome); 2010 Mar; 11(3):221-8. PubMed ID: 20550062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure.
    Feldman DS; Carnes CA; Abraham WT; Bristow MR
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):475-83. PubMed ID: 16265588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hope for a broken heart?
    Most P; Eicher C; Völkers M; Pleger ST; Katus HA
    Trends Biotechnol; 2004 Oct; 22(10):487-9. PubMed ID: 15450736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.